694
THE JOURNAL OF EXPERIMENTAL MEDICINE -VOLUME 142, 1975 Hemolytic Plaque-Forming Cell Assay. Direct plaque-forming cells (PFC) to (T,G)-A--L were measured as previously described (3, 4) using as indicators sheep red blood cells (SRBC) coated with (T,G)-Pro--L . PFC to (Phe,G)-A--L were estimated with SRBC coated with (Phe,G)-A--L . Sensitization of SRBC was accomplished using chromium chloride, as described previously (3, 4) .
Mice . Congenic-resistant strains on the C57BL/10ScSn (B10) background were used . B10, B10.D2, and B10.BR mice were obtained from the Laboratory Animal Centre, Carshalton, and bred at the Department of Pathology, Cambridge. B10.AQR and B10.A (4R) were the generous gift of Dr . H. Festenstein, London Hospital .
Strains A.TH, A.TL, and AQR used in the immunizations were bred at the Department of Human Genetics, University of Michigan, Ann Arbor, Mich . Table I shows the recombinant haplotypes of the strains used .
Sera . B10 anti-A/J and DBA/1 anti-B10 .A sera were raised by repeated immunization with A/J or B10.A spleen cells over several weeks. These sera were used unabsorbed and after adsorption with B10.A (4R) or B10.AQR spleen cells respectively .
B10.D2 anti-B10 .A serum was raised by first. skin grafting on days 0 and 27, followed by inoculation of 1/4 spleen equivalent of B10.A cells i.p . on days 41, 48, 55, and 62 . Mice were exsanguinated on day 69 . Similarly, B10.A anti-B10 .D2 serum was raised by repeated immunization with 1/4 spleen equivalent and 1/4 thymus equivalent of B10.D2 cells on days 0, 3, 7, 10, 14, 17, 21, and 24, after a single B10.D2 skin graft 5-11 wk previously . Mice were exsanguinated on day 34 . These sera were used both unadsorbed and after adsorption with red cells to remove anti-K antibodies . The activity of these sera has been described in detail elsewhere. ' A.TH anti-A .TL and AQR anti-B10 .A (10) were prepared by immunizations with splenic, thymic, and lymph node lymphocytes intraperitoneally for 4 wk, followed by monthly booster injections until a high cytotoxic titer was obtained .
Immunoadsorbents . These were prepared by coupling sera to CNBr-activated Sepharose as previously described (3) .
Results
Mapping of Genes Coding for Factor . T-cell factor specific for (T,G)-A--L was passed through columns of region-specific anti-H-2 sera immobilized on activated Sepharose, before transfer together with bone marrow cells and antigen into suitable irradiated recipients.
(a) Factor prepared in H-2k (B10.Br) mice was passed through columns containing antisera specific for the K region ofthe H-2'`haplotype (anti-K'°; AQR anti-B10 .A), or for theI (and S) regions ofthe same haplotye (anti-I' ; A-TH anti-A.TL) . As shown in Table II 
Strain
Haplotype origin of region
factor, indicating the factor contains a product of the I (or S) region . Further confirmation that the K region does not contribute to the factor was obtained by adsorption of an anti-H-2' serum (DBA/ anti-B10.A) with B10 .AQR spleen cells. After absorption this serum no longer removed the factor . (b) Our previously published results (3) have shown the factor to be a product of the left-hand side of the recombinant H-2 a chromosome, i. e. of the K, I-A or I-B regions, and since the data above rule out the K region as coding for the factor, it remained to be determined which of the I subregions was responsible . This was accomplished by removing from an anti-H-2 a serum (B10 anti-A/J) the antibodies reacting with the K and I-A regions by absorption with B10 .A (4R) spleen cells. Table III shows that after this absorption, the anti-H-2 a no longer removed the T-cell factor . These results are summarized in Fig . 1 , from which it can be seen that the factor must be coded for, at least in part, by the I-A subregion .
(c) The following results confirmed that the factor is coded by the I region, and not by the K locus. AntiK,I sera were rendered specific for the I region by (Table V) clearly show that the factor from each of these strains functioned equally well in combination with allogeneic or syngeneic bone marrow . We were unable to find any evidence of the type of restrictions reported for T cell-B cell interaction (6, 7).
Discussion
The results described here further define the genes coding for a T-cell product specific for (T,G)-A--L, and show that they lie in the I-A subregion of the H2 complex (Fig. 1) . This mapping has been accomplished using antisera raised specifically against I-region differences between otherwise congenic strains, or rendered specific for different regions of H2 by absorption. This takes the mapping of the (T,G)-A--L specific factor as far as is possible with the recombinants presently available . It is, of course, also important that the I-A subregion controls the level of immune response to the synthetic polypeptides built on A--L, of which (T,G)-A--L is one (11) . Although the genes for the (T, G)-A--L specific molecule map in this region, it does not automatically follow that responsiveness is always associated with a lack of this product . For example, low responders to (T,G)-A--L of H-2' haplotype produce the specific T-cell factor, but their bone marrow cells do not respond to active factor and antigen (4) . On the other hand, some low responder strains fail to make factor, e.g. SJL (12, 13) and B10M (unpublished observations), although bone marrow cells of B10 .M are responsive . This would suggest that at least two genes in the I-A region must be involved in genetic control of response to (T,G)-A--L, one coding for the T-cell factor (T-cell receptor?) while the other codes for the ability of B cells to respond to the factor/antigen signal. We are currently pursuing experiments designed to test this two-gene hypothesis.
We have also found that the T-cell factor is able to cooperate with allogeneic bone marrow cells as effectively as with syngeneic cells. Experiments testing cooperation between T cells and B cells-as opposed to T-cell factor and bone marrow cells-have indicated that the interacting cells must share certain H-2 specificities, notably those of the I-region (6, 7). Our results show that triggering ofbone marrow cells by the T-cell factor is not limited in this way, and thus infer that the histocompatibility restrictions on cooperation between cells may not be related to the triggering event itself. For example, cell approximation may require certain basic similarities in the surfaces of the cells involved; alternatively it might be necessary to avoid the recognition of B-cell I antigens by cooperating T cells . The process of B-cell triggering, which we are able to study in isolation using the soluble T-cell factor instead of T cells, seems not to require I-region identity, but is brought about by interactions between molecular structures which are common to all responder strains . These interacting structures are probably located in the T-cell receptor/factor molecule and on a site on B cells (or macrophages) where the T-cell signal is accepted.
Summary
Further mapping of the mouse T-cell factor specific for poly(Try,Glu)-polyDLAla--polyLys is reported . It is shown to be a product of the I-A subregion of the H-2complex by the use of antisera either raised specifically against or made specific, by absorption, for different regions of the H-2 complex . The factor cooperates across allogeneic barriers, e.g., when factor produced by one strain is combined with bone marrow cells of other H-2 incompatible strains .
